SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001829126-22-016171
Filing Date
2022-08-25
Accepted
2022-08-25 16:19:37
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2305
  Complete submission text file 0001829126-22-016171.txt   3667
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11190 BISCAYNE BLVD MIAMI FL 33181
Business Address
NATAN DAVID (Reporting) CIK: 0001253108 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 221197624